Opportunity to Co-Sponsor Office of Research Integrity Workshops, 40774 [2018-17615]
Download as PDF
<![CDATA[
40774
Federal Register / Vol. 83, No. 159 / Thursday, August 16, 2018 / Notices
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACRHHS
should be sent to Steven Hirsch, using
the contact information above at least 3
business days prior to the meeting.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Steven Hirsch at the address and
phone number listed above at least 10
business days prior to the meeting.
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–17623 Filed 8–15–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Opportunity to Co-Sponsor Office of
Research Integrity Workshops
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
The Office of Research
Integrity (ORI) announces the
opportunity for non-federal public and
private sector entities to co-sponsor ORI
conferences or workshops (ORI
Workshops). Potential co-sponsors must
have a demonstrated interest and
experience in the responsible conduct of
research (RCR) or the handling of
research misconduct allegations.
Potential co-sponsors must be willing to
participate substantively in the cosponsored activity.
Expressions of interest for cosponsorships of ORI Workshops are
received throughout the year at the
email address below. ORI co-sponsors a
limited number of workshops with other
entities each year. Expressions of
interest are being received for ORI
Workshops that will take place in the
next fiscal year (October 2018 through
September 2019) or beyond.
Expressions of interest for cosponsorships should be sent by email to
AskORI@HHS.GOV with ‘‘Cosponsorship for ORI Workshops’’ in the
subject field or by mail to ORI at 1101
Wootton Parkway, Suite 750, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Tracey Randolph, Program Analyst,
Office of Research Integrity, 1101
Wootton Parkway, Suite 750, Rockville,
MD 20852, (240) 453–8200.
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:15 Aug 15, 2018
Jkt 244001
ORI
oversees and directs U.S. Public Health
Service (PHS) research integrity
activities on behalf of the Secretary of
U.S. Department of Health and Human
Services (HHS), with the exception of
the regulatory research integrity
activities of the Food and Drug
Administration. ORI is a program office
within the Office of the Assistant
Secretary for Health, Office of the
Secretary, HHS.
ORI’s Division of Education and
Integrity (DEI) has among its duties the
responsibility to develop and
implement activities and programs to
teach RCR and train Research Integrity
Officers (RIOs) as well as others that are
involved in research integrity, such as
Institutional Officials (IOs) and
institutional counsel.
Consistent with ORI’s mission and the
applicable statutory authority, 42 U.S.C.
289b, ORI Workshops aim to provide
clarification and technical information
on the HHS regulations for handling
research misconduct allegations and on
education in RCR to foster integrity in
research. ORI Workshops are
moderately sized, convening over one to
three days, and typically accepting
between 20 and 50 attendees.
Co-sponsors will assist with
workshop and agenda development,
coordination, financial management,
and meeting logistics in conjunction
with ORI staff.
Co-sponsors can charge registration
fees to recover costs associated with the
events; however, co-sponsors may not
set registration fees at an amount higher
than necessary to recover related event
expenses. Further, co-sponsors are
solely responsible for collecting and
handling any registration fees collected.
Eligibility for Co-Sponsorship: The cosponsoring entity must have a
demonstrated interest and experience in
the RCR or the handling of research
misconduct allegations. The cosponsoring entity must participate
substantively in the co-sponsored
activity, not just provide funding or
logistical support.
Each co-sponsorship expression of
interest shall describe: (1) The entity’s
interest and goals in promoting research
integrity or the RCR, (2) the entity’s
prior experience and current readiness
to undertake the responsibilities
described above, (3) the type of event(s)
that the entity is interested in cosponsoring with ORI, (4) facilities
available for the event(s), and (5) any
current constraints with respect to dates
or facilities. The type of event may be
an event from ORI’s regular program of
recurring events (e.g., RCR Instructor’s
Workshop) or a special topic of mutual
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
interest to be developed jointly. The
expression of interest should be a
bulleted outline, no more than two
pages in length, single-spaced, and 11point font. An entity may submit an
expression of interest individually or
jointly with other entities describing
their relative contributions.
Evaluation Criteria: After engaging in
exploratory discussions with potential
co-sponsors that respond to this notice,
the following considerations will be
used by HHS officials, as appropriate
and relevant, to select the co-sponsor(s):
• Qualifications and capability to fulfill
co-sponsorship responsibilities
• suitability of the location of the
proposed event in terms of the overall
geographical distribution of ORI
events
• potential for reaching, generating, and
engaging adequate number of
attendees from stakeholders
• availability and description of
facilities needed to support the
workshop
• availability of administrative support
for the logistics of hosting such
workshops
The selected co-sponsoring
organization(s) shall furnish the
necessary personnel, materials, services,
and facilities to administer its
responsibility for the workshop. These
duties will be outlined in a cosponsorship agreement with ORI that
will set forth the details of the cosponsored activity, including the
requirements that any fees collected by
the co-sponsor shall be limited to the
amount necessary to cover the cosponsor’s related event expenses. This
co-sponsorship agreement does not
represent an endorsement by ORI of an
individual co-sponsor’s policies,
positions, or activities. Additionally,
this agreement will not affect any
determination concerning activities by
the co-sponsors that are regulated by
ORI.
Dated: August 9, 2018.
Scott J. Moore,
Deputy Director, Office of Research Integrity.
[FR Doc. 2018–17615 Filed 8–15–18; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
AGENCY:
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 83, Number 159 (Thursday, August 16, 2018)]
[Notices]
[Page 40774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17615]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Opportunity to Co-Sponsor Office of Research Integrity Workshops
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of Research Integrity (ORI) announces the
opportunity for non-federal public and private sector entities to co-
sponsor ORI conferences or workshops (ORI Workshops). Potential co-
sponsors must have a demonstrated interest and experience in the
responsible conduct of research (RCR) or the handling of research
misconduct allegations. Potential co-sponsors must be willing to
participate substantively in the co-sponsored activity.
Expressions of interest for co-sponsorships of ORI Workshops are
received throughout the year at the email address below. ORI co-
sponsors a limited number of workshops with other entities each year.
Expressions of interest are being received for ORI Workshops that will
take place in the next fiscal year (October 2018 through September
2019) or beyond.
Expressions of interest for co-sponsorships should be sent by email
to [email protected] with ``Co-sponsorship for ORI Workshops'' in the
subject field or by mail to ORI at 1101 Wootton Parkway, Suite 750,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Tracey Randolph, Program Analyst,
Office of Research Integrity, 1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453-8200.
SUPPLEMENTARY INFORMATION: ORI oversees and directs U.S. Public Health
Service (PHS) research integrity activities on behalf of the Secretary
of U.S. Department of Health and Human Services (HHS), with the
exception of the regulatory research integrity activities of the Food
and Drug Administration. ORI is a program office within the Office of
the Assistant Secretary for Health, Office of the Secretary, HHS.
ORI's Division of Education and Integrity (DEI) has among its
duties the responsibility to develop and implement activities and
programs to teach RCR and train Research Integrity Officers (RIOs) as
well as others that are involved in research integrity, such as
Institutional Officials (IOs) and institutional counsel.
Consistent with ORI's mission and the applicable statutory
authority, 42 U.S.C. 289b, ORI Workshops aim to provide clarification
and technical information on the HHS regulations for handling research
misconduct allegations and on education in RCR to foster integrity in
research. ORI Workshops are moderately sized, convening over one to
three days, and typically accepting between 20 and 50 attendees.
Co-sponsors will assist with workshop and agenda development,
coordination, financial management, and meeting logistics in
conjunction with ORI staff.
Co-sponsors can charge registration fees to recover costs
associated with the events; however, co-sponsors may not set
registration fees at an amount higher than necessary to recover related
event expenses. Further, co-sponsors are solely responsible for
collecting and handling any registration fees collected.
Eligibility for Co-Sponsorship: The co-sponsoring entity must have
a demonstrated interest and experience in the RCR or the handling of
research misconduct allegations. The co-sponsoring entity must
participate substantively in the co-sponsored activity, not just
provide funding or logistical support.
Each co-sponsorship expression of interest shall describe: (1) The
entity's interest and goals in promoting research integrity or the RCR,
(2) the entity's prior experience and current readiness to undertake
the responsibilities described above, (3) the type of event(s) that the
entity is interested in co-sponsoring with ORI, (4) facilities
available for the event(s), and (5) any current constraints with
respect to dates or facilities. The type of event may be an event from
ORI's regular program of recurring events (e.g., RCR Instructor's
Workshop) or a special topic of mutual interest to be developed
jointly. The expression of interest should be a bulleted outline, no
more than two pages in length, single-spaced, and 11-point font. An
entity may submit an expression of interest individually or jointly
with other entities describing their relative contributions.
Evaluation Criteria: After engaging in exploratory discussions with
potential co-sponsors that respond to this notice, the following
considerations will be used by HHS officials, as appropriate and
relevant, to select the co-sponsor(s):
Qualifications and capability to fulfill co-sponsorship
responsibilities
suitability of the location of the proposed event in terms of
the overall geographical distribution of ORI events
potential for reaching, generating, and engaging adequate
number of attendees from stakeholders
availability and description of facilities needed to support
the workshop
availability of administrative support for the logistics of
hosting such workshops
The selected co-sponsoring organization(s) shall furnish the
necessary personnel, materials, services, and facilities to administer
its responsibility for the workshop. These duties will be outlined in a
co-sponsorship agreement with ORI that will set forth the details of
the co-sponsored activity, including the requirements that any fees
collected by the co-sponsor shall be limited to the amount necessary to
cover the co-sponsor's related event expenses. This co-sponsorship
agreement does not represent an endorsement by ORI of an individual co-
sponsor's policies, positions, or activities. Additionally, this
agreement will not affect any determination concerning activities by
the co-sponsors that are regulated by ORI.
Dated: August 9, 2018.
Scott J. Moore,
Deputy Director, Office of Research Integrity.
[FR Doc. 2018-17615 Filed 8-15-18; 8:45 am]
BILLING CODE 4150-31-P
